TrialJournal of hematology & oncology2017

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.

Darius Juskevicius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.